Logo image of FIVE

FIVE BELOW (FIVE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FIVE - US33829M1018 - Common Stock

163.18 USD
+5.85 (+3.72%)
Last: 11/25/2025, 6:42:58 PM
163.18 USD
0 (0%)
After Hours: 11/25/2025, 6:42:58 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to FIVE. FIVE was compared to 122 industry peers in the Specialty Retail industry. FIVE has an excellent financial health rating, but there are some minor concerns on its profitability. FIVE shows excellent growth, but is valued quite expensive already. These ratings could make FIVE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year FIVE was profitable.
FIVE had a positive operating cash flow in the past year.
Each year in the past 5 years FIVE has been profitable.
Each year in the past 5 years FIVE had a positive operating cash flow.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of FIVE (5.93%) is better than 75.41% of its industry peers.
FIVE's Return On Equity of 14.32% is fine compared to the rest of the industry. FIVE outperforms 72.95% of its industry peers.
FIVE has a Return On Invested Capital of 7.11%. This is in the better half of the industry: FIVE outperforms 66.39% of its industry peers.
FIVE had an Average Return On Invested Capital over the past 3 years of 8.48%. This is below the industry average of 11.80%.
Industry RankSector Rank
ROA 5.93%
ROE 14.32%
ROIC 7.11%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

FIVE has a Profit Margin of 6.45%. This is amongst the best in the industry. FIVE outperforms 81.97% of its industry peers.
FIVE's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.26%, FIVE is in the better half of the industry, outperforming 78.69% of the companies in the same industry.
In the last couple of years the Operating Margin of FIVE has declined.
The Gross Margin of FIVE (35.06%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of FIVE has remained more or less at the same level.
Industry RankSector Rank
OM 8.26%
PM (TTM) 6.45%
GM 35.06%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FIVE is destroying value.
Compared to 1 year ago, FIVE has less shares outstanding
Compared to 5 years ago, FIVE has less shares outstanding
There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

FIVE has an Altman-Z score of 3.80. This indicates that FIVE is financially healthy and has little risk of bankruptcy at the moment.
FIVE has a Altman-Z score of 3.80. This is amongst the best in the industry. FIVE outperforms 82.79% of its industry peers.
There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.8
ROIC/WACC0.76
WACC9.31%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.71 indicates that FIVE should not have too much problems paying its short term obligations.
FIVE has a Current ratio of 1.71. This is in the better half of the industry: FIVE outperforms 73.77% of its industry peers.
FIVE has a Quick Ratio of 1.71. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.85, FIVE is in the better half of the industry, outperforming 69.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.85
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.30% over the past year.
FIVE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.07% yearly.
Looking at the last year, FIVE shows a quite strong growth in Revenue. The Revenue has grown by 13.88% in the last year.
FIVE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.99% yearly.
EPS 1Y (TTM)10.3%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%50%
Revenue 1Y (TTM)13.88%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.71%

3.2 Future

Based on estimates for the next years, FIVE will show a very strong growth in Earnings Per Share. The EPS will grow by 30.76% on average per year.
The Revenue is expected to grow by 16.48% on average over the next years. This is quite good.
EPS Next Y4.66%
EPS Next 2Y7.79%
EPS Next 3Y9.11%
EPS Next 5Y30.76%
Revenue Next Year18.08%
Revenue Next 2Y13.91%
Revenue Next 3Y12.2%
Revenue Next 5Y16.48%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.30 indicates a quite expensive valuation of FIVE.
FIVE's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of FIVE to the average of the S&P500 Index (25.98), we can say FIVE is valued inline with the index average.
A Price/Forward Earnings ratio of 27.86 indicates a quite expensive valuation of FIVE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FIVE is on the same level as its industry peers.
FIVE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 35.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.3
Fwd PE 27.86
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FIVE is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, FIVE is valued a bit cheaper than 67.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.07
EV/EBITDA 14.84
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates FIVE does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of FIVE may justify a higher PE ratio.
PEG (NY)6.28
PEG (5Y)2.91
EPS Next 2Y7.79%
EPS Next 3Y9.11%

0

5. Dividend

5.1 Amount

FIVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FIVE BELOW

NASDAQ:FIVE (11/25/2025, 6:42:58 PM)

After market: 163.18 0 (0%)

163.18

+5.85 (+3.72%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)12-02 2025-12-02
Inst Owners108.18%
Inst Owner Change-2.51%
Ins Owners0.94%
Ins Owner Change0.62%
Market Cap9.00B
Revenue(TTM)4.23B
Net Income(TTM)273.05M
Analysts74.19
Price Target167.2 (2.46%)
Short Float %6.15%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.15%
Min EPS beat(2)3.28%
Max EPS beat(2)29.03%
EPS beat(4)4
Avg EPS beat(4)44.81%
Min EPS beat(4)1.27%
Max EPS beat(4)145.65%
EPS beat(8)5
Avg EPS beat(8)21.71%
EPS beat(12)7
Avg EPS beat(12)22.92%
EPS beat(16)8
Avg EPS beat(16)19.36%
Revenue beat(2)1
Avg Revenue beat(2)-0.09%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)1.37%
Revenue beat(4)2
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)3.58%
Revenue beat(8)2
Avg Revenue beat(8)-0.86%
Revenue beat(12)3
Avg Revenue beat(12)-0.68%
Revenue beat(16)4
Avg Revenue beat(16)-0.82%
PT rev (1m)1.83%
PT rev (3m)16.52%
EPS NQ rev (1m)5.05%
EPS NQ rev (3m)1346.62%
EPS NY rev (1m)0.49%
EPS NY rev (3m)8.91%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)4.86%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)2.74%
Valuation
Industry RankSector Rank
PE 29.3
Fwd PE 27.86
P/S 2.13
P/FCF 26.07
P/OCF 16.11
P/B 4.72
P/tB 4.72
EV/EBITDA 14.84
EPS(TTM)5.57
EY3.41%
EPS(NY)5.86
Fwd EY3.59%
FCF(TTM)6.26
FCFY3.84%
OCF(TTM)10.13
OCFY6.21%
SpS76.74
BVpS34.58
TBVpS34.58
PEG (NY)6.28
PEG (5Y)2.91
Graham Number65.83
Profitability
Industry RankSector Rank
ROA 5.93%
ROE 14.32%
ROCE 9.49%
ROIC 7.11%
ROICexc 8.7%
ROICexgc 8.7%
OM 8.26%
PM (TTM) 6.45%
GM 35.06%
FCFM 8.16%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
ROICexc(3y)9.94%
ROICexc(5y)11.39%
ROICexgc(3y)9.94%
ROICexgc(5y)11.39%
ROCE(3y)11.31%
ROCE(5y)12.79%
ROICexgc growth 3Y-24.82%
ROICexgc growth 5Y-8.07%
ROICexc growth 3Y-24.82%
ROICexc growth 5Y-8.07%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
F-Score6
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 116.61%
Cap/Sales 5.04%
Interest Coverage 250
Cash Conversion 104.92%
Profit Quality 126.41%
Current Ratio 1.71
Quick Ratio 0.85
Altman-Z 3.8
F-Score6
WACC9.31%
ROIC/WACC0.76
Cap/Depr(3y)229.46%
Cap/Depr(5y)263.43%
Cap/Sales(3y)8.65%
Cap/Sales(5y)9.26%
Profit Quality(3y)40.25%
Profit Quality(5y)53.87%
High Growth Momentum
Growth
EPS 1Y (TTM)10.3%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%50%
EPS Next Y4.66%
EPS Next 2Y7.79%
EPS Next 3Y9.11%
EPS Next 5Y30.76%
Revenue 1Y (TTM)13.88%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.71%
Revenue Next Year18.08%
Revenue Next 2Y13.91%
Revenue Next 3Y12.2%
Revenue Next 5Y16.48%
EBIT growth 1Y-3.55%
EBIT growth 3Y-12.71%
EBIT growth 5Y8.3%
EBIT Next Year60.71%
EBIT Next 3Y26.38%
EBIT Next 5Y30.4%
FCF growth 1Y92.51%
FCF growth 3Y39.02%
FCF growth 5YN/A
OCF growth 1Y27.54%
OCF growth 3Y9.51%
OCF growth 5Y18.16%

FIVE BELOW / FIVE FAQ

What is the ChartMill fundamental rating of FIVE BELOW (FIVE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to FIVE.


What is the valuation status for FIVE stock?

ChartMill assigns a valuation rating of 3 / 10 to FIVE BELOW (FIVE). This can be considered as Overvalued.


Can you provide the profitability details for FIVE BELOW?

FIVE BELOW (FIVE) has a profitability rating of 6 / 10.


How financially healthy is FIVE BELOW?

The financial health rating of FIVE BELOW (FIVE) is 7 / 10.


What is the expected EPS growth for FIVE BELOW (FIVE) stock?

The Earnings per Share (EPS) of FIVE BELOW (FIVE) is expected to grow by 4.66% in the next year.